Nephrol Dial Transplant (2002) 17: 1936-1941
© 2002 European Renal Association-European Dialysis and Transplant Association
The role of theophylline in contrast-induced nephropathy: a case-control study
1 Department of Cardiology, 2 Department of Nephrology and 3 Department of Nuclear Medicine, Sanjay Gandhi PGIMS, Lucknow, India
Background. Various strategies for the prevention of contrast-induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN.
Methods. We randomized into two groups 70 patients with diabetes mellitus who were undergoing coronary angiography (CAG) with high-osmolar contrast media. Group I (n=35) underwent routine CAG, and group II (n=35) received oral theophylline 200 mg b.d. 24 h before and for 48 h after CAG. Serum Na+, K+, blood urea nitrogen (BUN), creatinine, osmolality, glomerular filtration rate (GFR) and urinalysis were performed before and after CAG. The 99mTc-DTPA-clearance method was used to assess GFR.
Results. Following angiography, patients in the control group showed a significant rise in serum creatinine (1.19±0.23 vs 1.44±0.32 mg/dl, P=0.003) and BUN (13.95±2.61 vs 17.55±3.9 mg/dl, P=0.01) along with a fall in GFR (85.4±14.7 vs 66.85±14.8 ml/min, P=0.008). The mean percentage fall in GFR was 35.8%. There was no significant change in serum creatinine (1.16±0.18 vs 1.24±0.21 mg/dl), BUN (12.8±3.36 vs 14.8±2.5 mg/dl) and GFR (86.8±15.8 vs 80.3±16.0 ml/min) in those receiving theophylline. No patient in the theophylline group had a >25% rise in serum creatinine, compared with 7/35 in the control group (P=0.017). In the control group, 11/35 (31%) developed CN, as demonstrated by a 
25% fall in GFR, while only one patient in the theophylline group had a fall in GFR (P=0.004). None of the pre-angiographic variables could predict the development of CN.
Conclusions. Following the use of high-osmolar contrast media for routine CAG, CN may develop in 31% of diabetic patients. Patients who received prophylactic oral theophylline had a significantly lower risk of CN than those who did not.
Keywords: acute renal failure; angiography; cardiac catheterization; radiocontrast-induced nephropathy; renal haemodynamics; theophylline
Correspondence and offprint requests to: Dr Aditya Kapoor, Assistant Professor, Department of Cardiology, Sanjay Gandhi PGIMS, Lucknow, India. Email: akapoor{at}sgpgi.ac.in
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Kelly, B. Dwamena, P. Cronin, S. J. Bernstein, and R. C. Carlos Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy Ann Intern Med, February 19, 2008; 148(4): 284 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network Prophylaxis Strategies for Contrast-Induced Nephropathy JAMA, June 21, 2006; 295(23): 2765 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huber, F. Eckel, M. Hennig, H. Rosenbrock, A. Wacker, D. Saur, A. Sennefelder, R. Hennico, C. Schenk, A. Meining, et al. Prophylaxis of Contrast Material-induced Nephropathy in Patients in Intensive Care: Acetylcysteine, Theophylline, or Both? A Randomized Study. Radiology, June 1, 2006; 239(3): 793 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Goldenberg and S. Matetzky Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies Can. Med. Assoc. J., May 24, 2005; 172(11): 1461 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Bagshaw and W. A. Ghali Theophylline for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis Arch Intern Med, May 23, 2005; 165(10): 1087 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Gleeson and S. Bulugahapitiya Contrast-Induced Nephropathy Am. J. Roentgenol., December 1, 2004; 183(6): 1673 - 1689. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maeder, M. Klein, T. Fehr, and H. Rickli Contrast nephropathy: Review focusing on prevention J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1763 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Ix, C. E. McCulloch, and G. M. Chertow Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2747 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Cox and J. P. Tsikouris Preventing Contrast Nephropathy: What Is the Best Strategy? A Review of the Literature J. Clin. Pharmacol., April 1, 2004; 44(4): 327 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Hoffmann, M. Fischereder, B. Kruger, W. Drobnik, and B. K. Kramer The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable J. Am. Soc. Nephrol., February 1, 2004; 15(2): 407 - 410. [Abstract] [Full Text] [PDF]
|
|